Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C11H15NO3 |
| Molecular Weight | 209.2417 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C2OCOC2=CC(CC(C)N)=C1
InChI
InChIKey=YQYUWUKDEVZFDB-UHFFFAOYSA-N
InChI=1S/C11H15NO3/c1-7(12)3-8-4-9(13-2)11-10(5-8)14-6-15-11/h4-5,7H,3,6,12H2,1-2H3
| Molecular Formula | C11H15NO3 |
| Molecular Weight | 209.2417 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Identification of compounds in the essential oil of nutmeg seeds (Myristica fragrans Houtt.) that inhibit locomotor activity in mice. | 2010-11-23 |
|
| Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin. | 2010-08 |
|
| Interactions of amphetamine analogs with human liver CYP2D6. | 1997-06-01 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:55:49 GMT 2025
by
admin
on
Mon Mar 31 17:55:49 GMT 2025
|
| Record UNII |
RG7FY73ZAA
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
PiHKAL
Created by
admin on Mon Mar 31 17:55:49 GMT 2025 , Edited by admin on Mon Mar 31 17:55:49 GMT 2025
|
||
|
WIKIPEDIA |
Designer-drugs-MMDA
Created by
admin on Mon Mar 31 17:55:49 GMT 2025 , Edited by admin on Mon Mar 31 17:55:49 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DB01442
Created by
admin on Mon Mar 31 17:55:49 GMT 2025 , Edited by admin on Mon Mar 31 17:55:49 GMT 2025
|
PRIMARY | |||
|
13674-05-0
Created by
admin on Mon Mar 31 17:55:49 GMT 2025 , Edited by admin on Mon Mar 31 17:55:49 GMT 2025
|
PRIMARY | |||
|
DTXSID50860757
Created by
admin on Mon Mar 31 17:55:49 GMT 2025 , Edited by admin on Mon Mar 31 17:55:49 GMT 2025
|
PRIMARY | |||
|
MMDA (DRUG)
Created by
admin on Mon Mar 31 17:55:49 GMT 2025 , Edited by admin on Mon Mar 31 17:55:49 GMT 2025
|
PRIMARY | |||
|
RG7FY73ZAA
Created by
admin on Mon Mar 31 17:55:49 GMT 2025 , Edited by admin on Mon Mar 31 17:55:49 GMT 2025
|
PRIMARY | |||
|
26175
Created by
admin on Mon Mar 31 17:55:49 GMT 2025 , Edited by admin on Mon Mar 31 17:55:49 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
TARGET -> AGONIST |
|
||
|
|
METABOLIC ENZYME -> INHIBITOR |
|
||
|
|
METABOLIC ENZYME -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|
